Cargando…
Essential information for neurorecovery clinical trial design: trajectory of global disability in first 90 days post-stroke in patients discharged to acute rehabilitation facilities
BACKGROUND: Many stroke recovery interventions are most beneficial when started 2-14d post-stroke, a time when patients become eligible for inpatient rehabilitation facilities (IRF) and neuroplasticity is often at its peak. Clinical trials focused on recovery need to expand the time from this plasti...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280859/ https://www.ncbi.nlm.nih.gov/pubmed/37340330 http://dx.doi.org/10.1186/s12883-023-03251-1 |
_version_ | 1785060889927352320 |
---|---|
author | Taleb, Shayandokht Lee, Jenny Ji-hyun Duncan, Pamela Cramer, Steven C. Bahr-Hosseini, Mersedeh Su, Michael Starkman, Sidney Avila, Gilda Hochberg, Arielle Hamilton, Scott Conwit, Robin A. Saver, Jeffrey L. |
author_facet | Taleb, Shayandokht Lee, Jenny Ji-hyun Duncan, Pamela Cramer, Steven C. Bahr-Hosseini, Mersedeh Su, Michael Starkman, Sidney Avila, Gilda Hochberg, Arielle Hamilton, Scott Conwit, Robin A. Saver, Jeffrey L. |
author_sort | Taleb, Shayandokht |
collection | PubMed |
description | BACKGROUND: Many stroke recovery interventions are most beneficial when started 2-14d post-stroke, a time when patients become eligible for inpatient rehabilitation facilities (IRF) and neuroplasticity is often at its peak. Clinical trials focused on recovery need to expand the time from this plasticity to later outcome timepoints. METHODS: The disability course of patients with acute ischemic stroke (AIS) and intracranial hemorrhage (ICH) enrolled in Field Administration of Stroke Therapy Magnesium (FAST-MAG) Trial with moderate-severe disability (modified Rankin Scale [mRS] 3–5) on post-stroke day4 who were discharged to IRF 2-14d post-stroke were analyzed. RESULTS: Among 1422 patients, 446 (31.4%) were discharged to IRFs, including 23.6% within 2-14d and 7.8% beyond 14d. Patients with mRS 3–5 on day4 discharged to IRFs between 2-14d accounted for 21.7% (226/1041) of AIS patients and 28.9% (110/381) of ICH patients, (p < 0.001). Among these AIS patients, age was 69.8 (± 12.7), initial NIHSS median 8 (IQR 4–12), and day4 mRS = 3 in 16.4%, mRS = 4 in 50.0%, and mRS = 5 in 33.6%. Among these ICH patients, age was 62.4 (± 11.7), initial NIHSS median 9 (IQR 5–13), day 4 mRS = 3 in 9.4%, mRS = 4 in 45.3%, and mRS = 5 in 45.3% (p < 0.01 for AIS vs ICH). Between day4 to day90, mRS improved ≥ 1 levels in 72.6% of AIS patients vs 77.3% of ICH patients, p = 0.3. For AIS, mRS improved from mean 4.17 (± 0.7) to 2.84 (± 1.5); for ICH, mRS improved from mean 4.35 (± 0.7) to 2.75 (± 1.3). Patients discharged to IRF beyond day14 had less improvement on day90 mRS compared with patients discharged between 2-14d. CONCLUSIONS: In this acute stroke cohort, nearly 1 in 4 patients with moderate-severe disability on post-stroke day4 were transferred to IRF within 2-14d post-stroke. ICH patients had nominally greater mean improvement on mRS day90 than AIS patients. This course delineation provides a roadmap for future rehabilitation intervention studies. |
format | Online Article Text |
id | pubmed-10280859 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102808592023-06-21 Essential information for neurorecovery clinical trial design: trajectory of global disability in first 90 days post-stroke in patients discharged to acute rehabilitation facilities Taleb, Shayandokht Lee, Jenny Ji-hyun Duncan, Pamela Cramer, Steven C. Bahr-Hosseini, Mersedeh Su, Michael Starkman, Sidney Avila, Gilda Hochberg, Arielle Hamilton, Scott Conwit, Robin A. Saver, Jeffrey L. BMC Neurol Research BACKGROUND: Many stroke recovery interventions are most beneficial when started 2-14d post-stroke, a time when patients become eligible for inpatient rehabilitation facilities (IRF) and neuroplasticity is often at its peak. Clinical trials focused on recovery need to expand the time from this plasticity to later outcome timepoints. METHODS: The disability course of patients with acute ischemic stroke (AIS) and intracranial hemorrhage (ICH) enrolled in Field Administration of Stroke Therapy Magnesium (FAST-MAG) Trial with moderate-severe disability (modified Rankin Scale [mRS] 3–5) on post-stroke day4 who were discharged to IRF 2-14d post-stroke were analyzed. RESULTS: Among 1422 patients, 446 (31.4%) were discharged to IRFs, including 23.6% within 2-14d and 7.8% beyond 14d. Patients with mRS 3–5 on day4 discharged to IRFs between 2-14d accounted for 21.7% (226/1041) of AIS patients and 28.9% (110/381) of ICH patients, (p < 0.001). Among these AIS patients, age was 69.8 (± 12.7), initial NIHSS median 8 (IQR 4–12), and day4 mRS = 3 in 16.4%, mRS = 4 in 50.0%, and mRS = 5 in 33.6%. Among these ICH patients, age was 62.4 (± 11.7), initial NIHSS median 9 (IQR 5–13), day 4 mRS = 3 in 9.4%, mRS = 4 in 45.3%, and mRS = 5 in 45.3% (p < 0.01 for AIS vs ICH). Between day4 to day90, mRS improved ≥ 1 levels in 72.6% of AIS patients vs 77.3% of ICH patients, p = 0.3. For AIS, mRS improved from mean 4.17 (± 0.7) to 2.84 (± 1.5); for ICH, mRS improved from mean 4.35 (± 0.7) to 2.75 (± 1.3). Patients discharged to IRF beyond day14 had less improvement on day90 mRS compared with patients discharged between 2-14d. CONCLUSIONS: In this acute stroke cohort, nearly 1 in 4 patients with moderate-severe disability on post-stroke day4 were transferred to IRF within 2-14d post-stroke. ICH patients had nominally greater mean improvement on mRS day90 than AIS patients. This course delineation provides a roadmap for future rehabilitation intervention studies. BioMed Central 2023-06-20 /pmc/articles/PMC10280859/ /pubmed/37340330 http://dx.doi.org/10.1186/s12883-023-03251-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Taleb, Shayandokht Lee, Jenny Ji-hyun Duncan, Pamela Cramer, Steven C. Bahr-Hosseini, Mersedeh Su, Michael Starkman, Sidney Avila, Gilda Hochberg, Arielle Hamilton, Scott Conwit, Robin A. Saver, Jeffrey L. Essential information for neurorecovery clinical trial design: trajectory of global disability in first 90 days post-stroke in patients discharged to acute rehabilitation facilities |
title | Essential information for neurorecovery clinical trial design: trajectory of global disability in first 90 days post-stroke in patients discharged to acute rehabilitation facilities |
title_full | Essential information for neurorecovery clinical trial design: trajectory of global disability in first 90 days post-stroke in patients discharged to acute rehabilitation facilities |
title_fullStr | Essential information for neurorecovery clinical trial design: trajectory of global disability in first 90 days post-stroke in patients discharged to acute rehabilitation facilities |
title_full_unstemmed | Essential information for neurorecovery clinical trial design: trajectory of global disability in first 90 days post-stroke in patients discharged to acute rehabilitation facilities |
title_short | Essential information for neurorecovery clinical trial design: trajectory of global disability in first 90 days post-stroke in patients discharged to acute rehabilitation facilities |
title_sort | essential information for neurorecovery clinical trial design: trajectory of global disability in first 90 days post-stroke in patients discharged to acute rehabilitation facilities |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280859/ https://www.ncbi.nlm.nih.gov/pubmed/37340330 http://dx.doi.org/10.1186/s12883-023-03251-1 |
work_keys_str_mv | AT talebshayandokht essentialinformationforneurorecoveryclinicaltrialdesigntrajectoryofglobaldisabilityinfirst90dayspoststrokeinpatientsdischargedtoacuterehabilitationfacilities AT leejennyjihyun essentialinformationforneurorecoveryclinicaltrialdesigntrajectoryofglobaldisabilityinfirst90dayspoststrokeinpatientsdischargedtoacuterehabilitationfacilities AT duncanpamela essentialinformationforneurorecoveryclinicaltrialdesigntrajectoryofglobaldisabilityinfirst90dayspoststrokeinpatientsdischargedtoacuterehabilitationfacilities AT cramerstevenc essentialinformationforneurorecoveryclinicaltrialdesigntrajectoryofglobaldisabilityinfirst90dayspoststrokeinpatientsdischargedtoacuterehabilitationfacilities AT bahrhosseinimersedeh essentialinformationforneurorecoveryclinicaltrialdesigntrajectoryofglobaldisabilityinfirst90dayspoststrokeinpatientsdischargedtoacuterehabilitationfacilities AT sumichael essentialinformationforneurorecoveryclinicaltrialdesigntrajectoryofglobaldisabilityinfirst90dayspoststrokeinpatientsdischargedtoacuterehabilitationfacilities AT starkmansidney essentialinformationforneurorecoveryclinicaltrialdesigntrajectoryofglobaldisabilityinfirst90dayspoststrokeinpatientsdischargedtoacuterehabilitationfacilities AT avilagilda essentialinformationforneurorecoveryclinicaltrialdesigntrajectoryofglobaldisabilityinfirst90dayspoststrokeinpatientsdischargedtoacuterehabilitationfacilities AT hochbergarielle essentialinformationforneurorecoveryclinicaltrialdesigntrajectoryofglobaldisabilityinfirst90dayspoststrokeinpatientsdischargedtoacuterehabilitationfacilities AT hamiltonscott essentialinformationforneurorecoveryclinicaltrialdesigntrajectoryofglobaldisabilityinfirst90dayspoststrokeinpatientsdischargedtoacuterehabilitationfacilities AT conwitrobina essentialinformationforneurorecoveryclinicaltrialdesigntrajectoryofglobaldisabilityinfirst90dayspoststrokeinpatientsdischargedtoacuterehabilitationfacilities AT saverjeffreyl essentialinformationforneurorecoveryclinicaltrialdesigntrajectoryofglobaldisabilityinfirst90dayspoststrokeinpatientsdischargedtoacuterehabilitationfacilities |